[76] [77] In a 72-week, phase IIIb open-label head-to-head trial of adults with obesity without diabetes, tirzepatide at the maximum tolerated dose produced greater mean weight loss than semaglutide and larger reductions in waist circumference, while gastrointestinal adverse events were the most common with both drugs
This might look like: Structuring our schedule around our energy, not expectations Creating a home and workspace that feels restorative Treating beauty, pleasure, and rest as essentialnot indulgent Designing our life is a form of self-respect
Interest in IGF-1 LR3 is generally seen in research and educational contexts related to regenerative medicine, metabolic health, and growth factor signaling pathways
This randomized, double-blind, controlled clinical trial was carried out at three teaching hospital-based dermatovenereology clinics in Indonesia
As we age, NAD+ levels naturally decline, which can impact energy, mental clarity, and cellular health
This waiting period helps differentiate between temporary medication effects and a more persistent digestive disorder
